Clinical Trials
All Clinical Trials - Page 68 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00291616Phase 4Completed
Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B
Thymosin-Alpha-1
- NCT00283062Phase 3Completed
Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy
Gonadorelin
- NCT00372697Phase 3Completed
Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
Octreotide
- NCT00254397Phase 2Completed
Melanoma Vaccine With Peptides and Leuprolide
Gonadorelin
- NCT01511692Phase 1Completed
Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes
Liraglutide
- NCT00254800Phase 1Completed
The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females
Exenatide
- NCT00259298Phase 4Completed
Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis
Teriparatide
- NCT00248157Phase 3Terminated
Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
Octreotide
- NCT00248131Phase 3Terminated
Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
Octreotide
- NCT01267669N/ACompleted
A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding
Octreotide
- NCT00259896Phase 1Completed
In-patient Study in Patients With Type 2 Diabetes Mellitus
Exenatide
- NCT00241423Phase 2Completed
Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes
Exenatide
- NCT00135330Phase 3Completed
An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT00240253Phase 4Completed
A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes
Pramlintide
- NCT00240045Phase 2/Phase 3Completed
The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction
Octreotide
- NCT00182754Phase 3Completed
Octreotide in Treating Patients With Cancer-Related Malignant Ascites
Octreotide
- NCT00128531Phase 3Completed
Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer
Gonadorelin
- NCT00417183Phase 4Unknown
Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation
Gonadorelin
- NCT00217659Phase 2Withdrawn
S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer
Gonadorelin
- NCT00189514Phase 2Completed
A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
Pramlintide
- NCT00229658N/ACompleted
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
Pramlintide
- NCT00221299Phase 4Completed
Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use
Teriparatide
- NCT00668941Phase 2Unknown
Cyclic Versus Daily Teriparatide on Bone Mass
Teriparatide
- NCT00239629Phase 4Completed
Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial
Teriparatide
- NCT00222092N/ACompleted
Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers
Octreotide
- NCT00332696Phase 2Completed
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
Octreotide
- NCT00332969Phase 2Completed
Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma
Octreotide
- NCT01613495N/AUnknown
Ghrelin Suppression by Octreotide in Prader-Willi
Octreotide
- NCT00375687N/AUnknown
Investigation of Early Hormonotherapy Efficacy of Prostate Cancer
Gonadorelin
- NCT00194792Phase 2Terminated
Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer
Gonadorelin
- NCT00225420Phase 1/Phase 2Completed
Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
Gonadorelin
- NCT01508806Phase 1Completed
Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function
Liraglutide
- NCT00228943N/ACompleted
The Role of Serotonin in Hot Flashes After Breast Cancer
KPV
- NCT00257426Phase 2Completed
Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Octreotide
- NCT02012166Phase 1Completed
A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)
Octreotide
- NCT00123253Phase 3Completed
TH9507 in Patients With HIV-Associated Lipodystrophy
Tesamorelin
- NCT00131469Phase 4Completed
Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta
Teriparatide
- NCT00804297Phase 3Completed
Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia
Octreotide
- NCT00112021Phase 2Completed
A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
Pramlintide
- NCT01014793N/ACompleted
Short and Long Term Efficacy of Combined Cabergoline and Octreotide Treatment in Acromegalic Patients
Octreotide
- NCT00742339Phase 2/Phase 3Terminated
Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome
Octreotide
- NCT00388804Phase 3Terminated
External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer
Gonadorelin
- NCT00103935Phase 2Completed
Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
Exenatide
- NCT00191867Phase 2Completed
Clinical Trial of Teriparatide in Japan
Teriparatide
- NCT00171613Phase 4Completed
A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients
Octreotide
- NCT01514487Phase 1Completed
Comparison of Three Liraglutide Formulations in Healthy Volunteers
Liraglutide
- NCT01110707Phase 2Completed
A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve
Gonadorelin
- NCT00172185Phase 3Completed
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
Teduglutide
- NCT00800930Phase 2Completed
Therapeutic Induction of Endogenous Antibiotics
Ll-37
- NCT01037699Phase 3Completed
Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles
Gonadorelin